By Vivian Ihechu As Nigeria and other African countries  continue to  seek ways to prevent malaria, monoclonal antibodies (mAbs) are offering a strong  hope. Dr Kayla Andrews, the Scientific Programme Leader at Bill and Melinda Gates Medical Research Institute (MRI), is giving this assurance. Andrews spoke about the Institute’s efforts in the clinical development of its Continue Reading